Pressmeddelanden

Eevia Health Plc - Notification of management's transactions

Eevia Health Plc has received the following notification pursuant to Article 19 of the Market Abuse Regulation:

____________________________________________

Person subject to the notification requirement

Name: Nurmi-Aro, Kim

Position: Chief Financial Officer

Issuer: Eevia Health Plc

LEI: 743700NO7D0UA8J1MQ31

Notification type: INITIAL NOTIFICATION

Reference number: 743700NO7D0UA8J1MQ31_20210621133215_4

____________________________________________

Transaction date: 2021-06-17

Venue: SPOTLIGHT (XSAT)

Instrument type: SHARE

ISIN: FI4000496658

Nature of the transaction: SUBSCRIPTION

Transaction details

(1): Volume: 13,200 Unit price: 0.745 EUR

Aggregated transactions

(1): Volume: 13,200 Volume weighted average price: 0.745 EUR

For more information, please contact: 

Kim Nurmi-Aro, CFO

kim@eeviahealth.com

Tel.: +358 504 44 0717

About Eevia

Eevia Health Plc, founded in March 2017, is a small, but fast-growing Finnish manufacturer of 100% organically certified plant extracts. The Company addresses significant health problems with bioactive compounds extracted from plant material from the pristine Finnish forests near the Arctic Circle. The extracts, which have scientifically documented health benefits, are sold B2B as ingredients to dietary supplements and food brands globally.

To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn @EeviaHealth.

2021-08-13
Regulatory

The Board and CEO of Eevia Health Plc hereby present the Interim Report for the second quarter 2021, covering the period April 1st through June 30th, 2021. The complete report with tables is attached to this release as a pdf-file. It is also available on the company website at www.eeviahealth.com 

2021-06-22
Regulatory

The Annual General Meeting of shareholders of Eevia Health Plc was held in Seinäjoki, on June 22, 2021. Two shareholders representing 3 797 500 shares and votes (36,14% of total shares) were represented at the meeting. The AGM decided each and all the proposals from the Board of Directors as described in the Notice of Annual General Meeting, unanimously.

2021-06-17
Regulatory

Eevia Health Plc ("Eevia"), a fast-growing functional foods company, today announces that the new share issue of approximately SEK 26.2 million prior to the planned listing on Spotlight Stock Market, was heavily oversubscribed. Subscriptions from over 3,500 investor accounts for a total subscription value of SEK 109.0 million means that the share issue was subscribed 4.16 times (or 416%).